Atrás
Rango del Día
$285.55
$299.30
Rango de 52 Semanas
$26.70
$356.00
Volumen
489,921
Promedio 50D / 200D
$312.99
/
$162.91
Cierre Anterior
$294.11
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -20.5 | 0.4 |
| P/B | 7.1 | 2.9 |
| ROE % | -45.8 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$510.40
+73.2%
Low: $83.00
High: $843.00
EPS Futuro
-$15.07
Ingresos Est.
6.4 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$59.55
$10.48 – $130.09
|
3.5 B | 5 |
| FY2029 |
$33.90
$5.97 – $74.06
|
2.2 B | 11 |
| FY2028 |
$9.61
-$8.88 – $31.39
|
1.1 B | 13 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -249.12M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-45.83%
ROIC-27.86%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio10.22
Interest Coverage0.00
Valoración
P/E Ratio
-20.54
P/B Ratio7.09
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -303.27M |
| ROE | -45.83% | ROA | -32.33% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -249.12M |
| ROIC | -27.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 10.22 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -20.54 | P/B Ratio | 7.09 |
| P/S Ratio | N/A | PEG Ratio | -0.68 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 6.23B | Enterprise Value | 5.87B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 8.55M | 2.45M | 0.0 | 0.0 |
| Net Income | -303.27M | -182.82M | -123.28M | -214.03M | -167.06M |
| EPS (Diluted) | -13.48 | -10.21 | -18.69 | -69.33 | -58.96 |
| Gross Profit | -140,000.0 | -143.86M | -84.32M | -154.44M | 0.0 |
| Operating Income | -326.20M | -200.17M | -126.37M | -214.99M | -167.33M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 937.91M | 483.11M | 87.95M | 115.13M | 292.75M |
| Total Liabilities | 59.77M | 37.66M | 18.28M | 39.02M | 41.94M |
| Shareholders' Equity | 878.14M | 445.45M | 69.67M | 76.11M | 250.81M |
| Total Debt | 110,000.0 | 1.37M | 2.50M | 3.50M | 4.31M |
| Cash & Equivalents | 357.33M | 215.37M | 81.30M | 61.62M | 138.70M |
| Current Assets | 610.91M | 404.37M | 84.88M | 110.84M | 287.41M |
| Current Liabilities | 59.77M | 37.55M | 15.75M | 34.35M | 38.43M |